Tilray (NASDAQ:TLRY) Shares Up 0.9% - Should You Buy?

Tilray Inc (NASDAQ:TLRY - Get Free Report) shares were up 0.9% during mid-day trading on Tuesday . The company traded as high as $1.75 and last traded at $1.75. Approximately 7,329,748 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 25,050,459 shares. The stock had previously closed at $1.73.

Analyst Upgrades and Downgrades

Separately, Roth Mkm dropped their price objective on Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a report on Friday, October 11th.

Tilray Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. The stock has a fifty day simple moving average of $1.71 and a 200-day simple moving average of $1.79. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of -3.96 and a beta of 2.13.

Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.04). The company had revenue of $200.00 million for the quarter, compared to analysts' expectations of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. Tilray's revenue was up 13.0% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) EPS. On average, equities research analysts anticipate that Tilray Inc will post -0.14 EPS for the current year.

Institutional Investors Weigh In On Tilray

Several large investors have recently modified their holdings of TLRY. Madrona Financial Services LLC acquired a new position in shares of Tilray during the 1st quarter worth $124,000. SpiderRock Advisors LLC purchased a new stake in Tilray during the first quarter worth approximately $247,000. Private Advisor Group LLC increased its holdings in Tilray by 7.3% in the 1st quarter. Private Advisor Group LLC now owns 175,845 shares of the company's stock valued at $434,000 after purchasing an additional 12,021 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Tilray by 8.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company's stock valued at $6,699,000 after buying an additional 213,834 shares during the period. Finally, Capstone Investment Advisors LLC raised its stake in shares of Tilray by 320.9% during the first quarter. Capstone Investment Advisors LLC now owns 95,736 shares of the company's stock valued at $236,000 after purchasing an additional 72,989 shares during the period. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.